SOL-1 data show OTX-TKI extends rescue-free control in treatment-naive wet AMD, shaping AI-driven trial design and longer-interval care. Barakat opened by highlighting what makes CTS uniquely valuable ...
Learn how FDA’s interchangeable ranibizumab biosimilar may streamline injections, cut costs, and guide safe switching for retina patients. Following the FDA approval of ranibizumab-hkdz (Ranluspec; ...
Meeting founder and co-chair Arshad M. Khanani, MD, MA, FASRS, shares what attendees can expect during this year's program, opening the evening of June 12 and running through June 13 in Las Vegas, ...
The US Food and Drug Administration (FDA) issued draft guidance to help developers bring promising gene therapies to patients more efficiently by making greater use of existing scientific and ...
Patent milestones: granted in Singapore; notices of allowance in Canada and Japan; applications pending in Europe, the US, India, and South Korea. Technology: induced pluripotent stem cells-derived ...
Therini Bio begins a phase 1b DME trial of THN391, an intravitreal antibody targeting fibrin-driven retinal inflammation. Therini Bio has dosed the first patients in a phase 1b multiple ascending dose ...
Researchers report pseudophakic patients implanted with a peripheral vision IOL detected roadway hazards significantly faster than those receiving a standard monofocal lens.
Alkeus Pharmaceuticals has dosed the first participant in the phase 3 NORTHSTAR trial of oral gildeuretinol for Stargardt disease, a condition with no approved treatments. Alkeus Pharmaceuticals in a ...
Researchers report pseudophakic patients implanted with a peripheral vision IOL detected roadway hazards significantly faster than those receiving a standard monofocal lens.
StemSight secures new patents for scalable induced pluripotent stem cells-derived limbal stem cells, boosting STE-101’s path to off-the-shelf limbal stem cell deficiency therapy and upcoming Series A.
A retrospective study identifies thin choroid as the key factor behind ungradable ultrawidefield green-light fundus autofluorescence images in geographic atrophy. This retrospective, cross-sectional ...
Researchers from Johnson & Johnson Vision and Aier Eye Hospital present 24-month prospective data showing that Chinese children wearing Abiliti™ 1-Day contact lenses experienced approximately half the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results